This bill (S 3384) requires the Health and Human Services (HHS) and Treasury Secretaries to conduct annual fraud risk assessments of Obamacare subsidy programs (premium tax credits) by December 2025 and each year after. It directs them to document all fraud prevention controls used for these subsidies and submit detailed reports to specific congressional committees and the HHS Inspector General. The assessments must follow a 2015 federal fraud management framework established by the Comptroller General. The bill directly affects HHS and Treasury operations related to administering health insurance subsidies under the Affordable Care Act.
HRES 932 is a symbolic resolution passed by the House of Representatives that condemns six specific members of Congress (including Senators Kelly and Slotkin and Representatives Crow, Deluzio, Goodlander, and Houlahan) for allegedly making statements that encouraged military and intelligence personnel to disobey orders from the President. The resolution claims these lawmakers falsely suggested the administration issued "illegal orders" and undermined the military chain of command, violating the Uniform Code of Military Justice (UCMJ). It does not create new laws or policies but formally denounces the lawmakers' statements as "dangerous and seditious rhetoric." As a procedural resolution, it has no binding effect on military conduct or policy.
The PBM Price Transparency and Accountability Act requires pharmacy benefit managers (PBMs) to be more transparent about drug pricing and ensure accurate payments to pharmacies. It establishes national average drug acquisition cost benchmarks for Medicaid, prohibits PBMs from keeping excessive profits through "spread pricing," and mandates detailed reporting of drug pricing, rebates, and fees. The bill affects Medicaid programs, Medicare Part D plans, and the PBMs that negotiate drug prices on behalf of insurers. It includes enforcement mechanisms like civil penalties for non-compliance and requires PBMs to report detailed pricing information to the Secretary of Health and Human Services.
The Back the Blue Act of 2025 creates new federal criminal offenses for killing or assaulting law enforcement officers, judges, and certain public safety personnel (including firefighters and first responders) while they are on duty or because of their official status. It increases penalties for these crimes, including minimum 10-year prison terms for killing officers and longer sentences for assaults causing serious injury, with the death penalty possible for killings. The bill also adds a "flight to avoid prosecution" provision for those fleeing to evade charges for killing officers, expands law enforcement officers' rights to carry firearms in certain circumstances, and limits federal habeas corpus relief for individuals convicted of killing law enforcement officers. This legislation directly affects law enforcement officers, judges, and public safety personnel, as well as individuals who commit violence against them.
This bill transfers unused funds from the Internal Revenue Code's Section 9006(a) fund to the Unemployment Trust Fund's Employment Security Administration Account. The funds will support state programs providing reemployment services and eligibility assessments for unemployment benefits. It directly affects state unemployment agencies administering these services by providing additional resources for job training and benefit verification. The change involves reallocating existing unobligated funds without creating new taxes or spending.
HR 6442, the Supporting Healthy Pregnancy Act, requires states to establish child support obligations for biological fathers to pay at least 50% of a mother's reasonable out-of-pocket medical expenses related to pregnancy and delivery, but only if the mother requests it. The bill directly affects biological fathers (who must pay), mothers (who can request payment), and state child support enforcement systems (which must implement the requirement). Key provisions include excluding abortion-related expenses from coverage and defining abortion to clarify that expenses for terminating a pregnancy (except for specific medical reasons like ectopic pregnancy) do not qualify. The law would take effect January 1 of the first year after enactment, with states needing time to update their plans if state legislation is required.
HR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.
HR 6446 modifies how U.S. customs officials investigate suspected evasion of antidumping and countervailing duty orders on imported goods. It allows the Commissioner to start an investigation independently if they have evidence of evasion, not just when a complaint is filed. Additionally, importers found to have evaded duties must pay all owed customs fees before they can challenge the decision in court. These changes streamline enforcement and clarify the process for addressing duty evasion.
HR 6423, the HELP Copays Act, requires health insurance plans and coverage to count financial assistance from non-profits or drug manufacturers toward patient cost-sharing limits like deductibles and copayments. This directly affects patients enrolled in health insurance who receive such assistance for prescription drugs, ensuring the help they get reduces their out-of-pocket costs faster. The bill amends key health laws to mandate that these payments are included when calculating whether a patient has met their deductible or copayment threshold. The change applies to all prescription drugs, including specialty drugs and those subject to prior authorization, but does not alter how insurers manage drug access through tools like step therapy. It takes effect for plan years starting in 2026.
HRES 925 is a non-binding resolution condemning the Iranian government's ongoing persecution of the Baha'i religious minority. It directly affects Baha'is in Iran, who face systemic discrimination, imprisonment, denial of education and employment, and violence due to their faith. The resolution calls on Iran to immediately release Baha'i prisoners, end hate propaganda targeting them, and reverse policies banning their access to education and jobs. It also urges the U.S. President and Secretary of State to demand Iran's compliance and use existing sanctions authorities against officials responsible for human rights abuses against Baha'is.
The FAIR Leave Act (S 3321) repeals a 12-month waiting period requirement under the Family and Medical Leave Act (FMLA) for spouses seeking leave. It directly affects spouses of employees covered by FMLA, removing a previous barrier to immediate eligibility. The key provision eliminates Section 102(f) of the FMLA, which had required spouses to work for 12 months before qualifying for leave. This change allows spouses to access FMLA leave from their first day of employment, without waiting for a year. The bill makes no other changes to FMLA provisions.
HR 6394, the Midwives for MOMS Act of 2025, provides federal grants to fund midwifery education programs at accredited colleges and universities. It allocates $15 million annually for general midwifery schools (50% for student support, 25% for program expansion, 25% for clinical supervisors) and $20 million annually for nurse-midwifery programs with similar funding splits. Priority is given to institutions serving rural areas, economically disadvantaged communities, and health professional shortage areas. The bill directly affects midwifery and nurse-midwifery education programs, excluding those within nursing schools, to expand training capacity.
